Abstract
The endothelial cell plays a central role in the control of inflammatory processes. The recruitment of inflammatory leucocytes into the blood vessels is controlled by the expression of adhesion molecules on the endothelium as well as the secretion and presentation of chemokines. Indoleamine 2,3 dioxygenase (IDO) is an enzyme that metabolises tryptophan and is known to be central in the regulation of immune responses. IDO can be expressed on endothelial cells and can alter T-cell responses to the endothelium. We show that IDO can be readily transfected in primary endothelial cells and detail a method to determine the activity of the transfected protein.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nourshargh S, Marelli-Berg FM. (2005) Transmigration through venular walls: a key regulator of leukocyte phenotype and function. Trends Immunol 26(3), 157–65.
Choi J, Enis DR, Koh KP, Shiao SL, Pober JS. (2004) T lymphocyte-endothelial cell interactions. Annu Rev Immunol 22, 683–709.
Savage CO, Hughes CC, McIntyre BW, Picard JK, Pober JS. (1993) Human CD4+ T cells proliferate to HLA-DR+ allogeneic vascular endothelium. Identification of accessory interactions. Transplantation 56(1), 128–34.
Page CS, Holloway N, Smith H, Yacoub M, Rose ML. (1994) Alloproliferative responses of purified CD4+ and CD8+ T cells to endothelial cells in the absence of contaminating accessory cells. Transplantation 57(11), 1628–37.
Ma W, Pober JS. (1998) Human endothelial cells effectively costimulate cytokine production by, but not differentiation of, naive CD4+ T cells. J Immunol 161(5), 2158–67.
Berg LP, James MJ, Alvarez-Iglesias M, Glennie S, Lechler RI, Marelli-Berg FM. (2002) Functional consequences of noncognate interactions between CD4+ memory T lymphocytes and the endothelium. J Immunol 168(7), 3227–34.
Marelli-Berg FM, Frasca L, Weng L, Lombardi G, Lechler RI. (1999) Antigen recognition influences transendothelial migration of CD4+ T cells. J Immunol 162(2), 696–703.
Mellor AL, Munn DH. (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4(10), 762–74.
Grohmann U, Fallarino F, Puccetti P. (2003) Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol 24(5), 242–8.
Lee GK, Park HJ, Macleod M, Chandler P, Munn DH, Mellor AL. (2002) Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division. Immunology 107(4), 452–60.
Terness P, Bauer TM, Röse L, Dufter C, Watzlik A, Simon H, Opelz G. (2002) Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 196(4), 447–57.
Däubener W, Spors B, Hucke C, Adam R, Stins M, Kim KS, Schroten H. (2001) Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase. Infect Immun 69(10), 6527–31.
Hansen AM, Ball HJ, Mitchell AJ, Miu J, Takikawa O, Hunt NH. (2004) Increased expression of indoleamine 2,3-dioxygenase in murine malaria infection is predominantly localised to the vascular endothelium. Int J Parasitol 34(12), 1309–19.
Schroten H, Spors B, Hucke C, Stins M, Kim KS, Adam R, Däubener W. (2001) Potential role of human brain microvascular endothelial cells in the pathogenesis of brain abscess: inhibition of Staphylococcus aureus by activation of indoleamine 2,3-dioxygenase. Neuropediatrics 32(4), 206–10.
Adam R, Rüssing D, Adams O, Ailyati A, Sik Kim K, Schroten H, Däubener W. (2005) Role of human brain microvascular endothelial cells during central nervous system infection. Significance of indoleamine 2,3-dioxygenase in antimicrobial defence and immunoregulation. Thromb Haemost 94(2), 341–6.
Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB. (2002) Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196(4), 459–68.
Beutelspacher SC, Tan PH, McClure MO, Larkin DF, Lechler RI, George AJ. (2006) Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses. Am J Transplant 6(6), 1320–30.
Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, Bianchi R, Belladonna ML, Fioretti MC, Alegre ML, Puccetti P. (2003) Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 4(12), 1206–12.
Puccetti P, Grohmann U. (2007) IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. Nat Rev Immunol 7(10), 817–23.
Beutelspacher SC, Pillai R, Watson MP, Tan PH, Tsang J, McClure MO, George AJ, Larkin DF. (2006) Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol 36(3), 690–700.
Witkiewicz A, Williams TK, Cozzitorto J, Durkan B, Showalter SL, Yeo CJ, Brody JR. (2008) Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection. J Am Coll Surg 206(5), 849–54.
Munn DH, Mellor AL. (2007) Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 117(5), 1147–54.
Fujigaki S, Saito K, Takemura M, Maekawa N, Yamada Y, Wada H, Seishima M. (2002) L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase. Infect Immun 70(2), 779–86.
Oh GS, Pae HO, Choi BM, Chae SC, Lee HS, Ryu DG, Chung HT. (2004) 3-Hydroxyanthranilic acid, one of metabolites of tryptophan via indoleamine 2,3-dioxygenase pathway, suppresses inducible nitric oxide synthase expression by enhancing heme oxygenase-1 expression. Biochem Biophys Res Commun 320(4), 1156–62.
Tan PH, Chan C, Xue SA, Dong R, Ananthesayanan B, Manunta M, Kerouedan C, Cheshire NJW, Wolfe JH, Haskard DO, Taylor KM, George AJT. (2004) Phenotypic and functional differences between human saphenous vein (HSVEC) and umbilical vein (HUVEC) endothelial cells. Atherosclerosis 173, 171–83.
Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82(13), 1107–12.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Mouratidis, P.X.E., George, A.J.T. (2010). Transfection of Indoleamine 2,3 Dioxygenase in Primary Endothelial Cells. In: Marelli-Berg, F., Nourshargh, S. (eds) T-Cell Trafficking. Methods in Molecular Biology, vol 616. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-461-6_10
Download citation
DOI: https://doi.org/10.1007/978-1-60761-461-6_10
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-460-9
Online ISBN: 978-1-60761-461-6
eBook Packages: Springer Protocols